“…The primary aim of the proposed project is to elucidate real and perceived barriers to access among medically indicated MC consumers. “

Principal Investigators:

Zach Walsh,  Robert Callaway

Co-Investigators:

Jamie Marshall, Susan Holtzman, Michael Woodworth

Health Canada initiated the medical cannabis program in 1999. However, despite official recognition of the need to provide for efficient administration of medical cannabis, evidence suggests that medically indicated Canadians face substantial barriers to accessing medical cannabis. These barriers are not well understood and the primary aim of the proposed project is to elucidate real and perceived barriers to access among medically indicated MC consumers.